| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
disease | 1.000 | None | 0.969 | 4 | 0 | 1994 | 2020 | ||||||||
|
proliferating cell nuclear antigen | 0.382 | 0.846 | 0.98 |
|
disease | 0.300 | None | 0.956 | 4 | 0 | 1993 | 2019 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.600 | None | 1.000 | 4 | 0 | 1985 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 1A | 0.403 | 0.769 | 1.9E-03 |
|
disease | 0.300 | None | 0.959 | 4 | 0 | 1996 | 2019 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
disease | 0.300 | None | 0.994 | 4 | 0 | 1996 | 2019 | ||||||||
|
TIMP metallopeptidase inhibitor 1 | 0.380 | 0.885 | 0.50 |
|
disease | 0.100 | None | 1.000 | 4 | 0 | 1993 | 2019 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.100 | None | 1.000 | 3 | 0 | 2004 | 2019 | ||||||||
|
hepatocyte growth factor | 0.374 | 0.885 | 1.00 |
|
disease | 0.400 | None | 1.000 | 3 | 0 | 1992 | 2020 | ||||||||
|
C-C motif chemokine ligand 20 | 0.474 | 0.846 | 2.4E-04 |
|
disease | 0.100 | None | 0.923 | 3 | 0 | 2003 | 2019 | ||||||||
|
gap junction protein alpha 1 | 0.393 | 0.885 | 0.16 |
|
disease | 0.060 | None | 0.833 | 3 | 0 | 1990 | 2019 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 0.400 | None | 0.980 | 3 | 0 | 1995 | 2019 | ||||||||
|
cytochrome P450 family 2 subfamily E member 1 | 0.459 | 0.885 | 8.1E-09 |
|
disease | 0.400 | None | 0.879 | 3 | 0 | 1995 | 2019 | ||||||||
|
basigin (Ok blood group) | 0.458 | 0.769 | 2.6E-05 |
|
disease | 0.100 | None | 0.978 | 3 | 0 | 2003 | 2019 | ||||||||
|
glutathione S-transferase pi 1 | 0.383 | 0.923 | 1.4E-02 |
|
disease | 0.400 | None | 0.950 | 3 | 0 | 1988 | 2020 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.400 | None | 0.985 | 3 | 0 | 1985 | 2020 | ||||||||
|
X-linked inhibitor of apoptosis | 0.447 | 0.808 | 0.92 |
|
disease | 0.100 | None | 1.000 | 3 | 0 | 2003 | 2019 | ||||||||
|
caspase 3 | 0.351 | 0.923 | 0.10 |
|
disease | 0.300 | None | 1.000 | 3 | 0 | 2000 | 2020 | ||||||||
|
heme oxygenase 1 | 0.381 | 0.923 | 9.7E-03 |
|
disease | 0.100 | None | 1.000 | 3 | 0 | 2002 | 2019 | ||||||||
|
glutathione S-transferase mu 1 | 0.380 | 0.923 | 2.1E-03 |
|
disease | 0.400 | None | 0.857 | 3 | 0 | 1995 | 2020 | ||||||||
|
suppressor of cytokine signaling 1 | 0.445 | 0.808 | 0.59 |
|
disease | 0.100 | None | 0.971 | 3 | 0 | 2001 | 2019 | ||||||||
|
keratin 19 | 0.460 | 0.731 | 4.3E-03 |
|
disease | 0.100 | None | 0.979 | 3 | 0 | 1996 | 2020 | ||||||||
|
Ras association domain family member 1 | 0.420 | 0.808 | 4.9E-06 |
|
disease | 0.100 | None | 0.979 | 3 | 0 | 2002 | 2020 | ||||||||
|
DLC1 Rho GTPase activating protein | 0.529 | 0.731 | 1.00 |
|
disease | 0.200 | None | 1.000 | 3 | 0 | 2000 | 2019 | ||||||||
|
protein tyrosine kinase 2 | 0.497 | 0.808 | 1.00 |
|
disease | 0.600 | None | 1.000 | 3 | 0 | 2003 | 2020 | ||||||||
|
cadherin 2 | 0.535 | 0.731 | 0.99 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2006 | 2008 |